HealthWarehouse.com, Inc. · OTC:HEWA

HealthWarehouse.com — Proxy Contest (August 2016)

16 slides from HealthWarehouse.com's proxy contest presentation, Aug 24, 2016

  1. Slide 1: Contested Board of Director Vote

    Contested Board of Director Vote Rx Investor Value Corporation www.rxinvestors.com August 22, 2016

  2. Slide 2: Disclaimer

    Disclaimer 8/22/16 Rx Investor Value Corporation 2 The views expressed herein represent the subjective opinions of Rx Investor Value Corporation and certain of its affiliates and controlling persons (collectively, “RIVC”), which beneficially own shares of HealthWarehouse . Com Inc (the “Company”) .

  3. Slide 3: RIVC Proposal to Shareholders

    RIVC Proposal to Shareholders 8/22/16 Rx Investor Value Corporation 3 The board has had ample time to turn around the company No plan to increase shareholder value The board’s disclosed actions are questionable Shareholder dilution, lender payables exchange, guaranteed bonuses, increased director pa

  4. Slide 4: How Long Does It Take To Turn Around HEWA? Ecommerce growth vs revenue decline

    How Long Does It Take To Turn Around HEWA? 8/22/16 Rx Investor Value Corporation 4 Since 2011 ecommerce has grown 14.6% per annum Yet in the same time period revenue has declined 9.3% per annum $0 $50,000 $100,000 $150,000 $200,000 $250,000 $300,000 $350,000 $400,000 2011 2012 2013 2014 2015 U.S. Ec

  5. Slide 5: How Long Does It Take To Turn Around HEWA? Working capital deficit

    How Long Does It Take To Turn Around HEWA? 8/22/16 Rx Investor Value Corporation 5 The company has disclosed its inability to secure adequate financial resources since 2011 (Source: HEWA Form 10 - K FN #2: 2011 to 2015) ($2,404,464) ($8,395,171) ($4,533,555) ($4,237,165) ($4,377,000) 2011 2012 2013

  6. Slide 6: How Long Does It Take To Turn Around HEWA? Share price decline

    How Long Does It Take To Turn Around HEWA? 8/22/16 Rx Investor Value Corporation 6 Share price has declined 94% since its $7.74 high on June 5, 2012 $0 $1 $2 $3 $4 $5 $6 $7 $8 $9 8/22/2011 8/22/2012 8/22/2013 8/22/2014 8/22/2015 HEWA Closing Price Aug 22, 2011 to Aug 19, 2016

  7. Slide 7: Current Board of Directors' Plan Has Not Delivered Shareholder Value

    Current Board of Directors’ Plan Has Not Delivered Shareholder Value 8/22/16 Rx Investor Value Corporation 7 The board has no apparent marketing plan to create value All of 27% 2Q16 y/y growth concentrated in 1Q16 when Consumer Reports favorably reviewed HEWA (Source: HEWA Form 10 - K,10 - Q’s ) Aug

  8. Slide 8: Consumer Reports Not a Marketing Strategy

    Consumer Reports Not a Marketing Strategy 8/22/16 Rx Investor Value Corporation 8 +29% y/y 2Q16 growth concentrated in +27% 1Q16 2Q16 returned to anemic growth Consumer Reports Article dated 01.05.15

  9. Slide 9: 38% of 2016 Share Price Gain is post RIVC prelim proxy

    38% of 2016 Share Price Gain is post RIVC prelim proxy 8/22/16 Rx Investor Value Corporation 9 Company proxy reports …”common stock has more than DOUBLED since the end of 2015” $0.00 $0.05 $0.10 $0.15 $0.20 $0.25 $0.30 $0.35 $0.40 $0.45 $0.50 12/31/2015 1/31/2016 2/29/2016 3/31/2016 4/30/2016 5/31/2

  10. Slide 10: RIVC Plans to Increase Share Price for Shareholders to Realize a Gain

    RIVC Plans to Increase Share Price for Shareholders to Realize a Gain 8/22/16 Rx Investor Value Corporation 10 Infuse permanent capital to Assure the company’s going concern status Fund new customer acquisition Drive consistent new revenue growth Disciplined, data driven customer acquisition Open ne

  11. Slide 11: RIVC Day Plan

    RIVC 90 Day Plan 8/22/16 Rx Investor Value Corporation 11 Set board calendar; establish committees/ charters Replace senior lender with permanent financing Secure employee support of RIVC’s strategic plan Negotiate vendor payables settlements; cement continuing partnerships Review/ improve customer

  12. Slide 12: RIVC Directors Have Relevant Experience

    RIVC Directors Have Relevant Experience RIVC Qualifications Current Board 8/22/16 Rx Investor Value Corporation 12 Successful Tech entrepreneur Pharmacist Two directors started on - line pharmacies Major investor who bought shares w own cash Public company CFO & director Investment banker specializi

  13. Slide 13: Current Directors – What Are They Doing?

    Current Directors – What Are They Doing? 8/22/16 Rx Investor Value Corporation 13 In the last director election, each director did not received a majority vote of the non - insider shares Two director slated elected with only 9% non - insider vote Two other directors received 22% and 31% of non - in

  14. Slide 14: Board's Record of Diluting Shareholders

    Board’s Record of Diluting Shareholders 8/22/16 Rx Investor Value Corporation 14 12% dilution occurred just prior to the record date and in front of announcement to explore the sale of HEWA The board has significantly diluted existing shareholders without any new capital entering HEWA (Source: HEWA

  15. Slide 15: Questionable Disclosure, Governance and Related Party Dealing

    Questionable Disclosure, Governance and Related Party Dealing ? 8/22/16 Rx Investor Value Corporation 15 Source: HEWA 2015 Form 10 - K $0.00 $0.05 $0.10 $0.15 $0.20 $0.25 $0.30 $0.35 Payables Exchange Rate 28-jul-16 close HEWA Share Price Source: HEWA SC 13D 08.15.16; http://www.nasdaq.com/symbol/he

  16. Slide 16: Disclaimer

    Disclaimer 8/22/16 Rx Investor Value Corporation 16 RX INVESTOR VALUE CORPORATION, TOGETHER WITH ITS DIRECTOR CANDIDATES JEFFREY HOLTMEIER, MARK SCOTT, DR . STEPHEN J . WEISS, JR . , AND BRIAN ROSS (THE “PARTICIPANTS”) HAVE FILED WITH THE SECURITES AND EXCHANGE COMMISSION (THE “SEC”) ON SCHEDULE 14

HealthWarehouse.com — Proxy Contest (August 2016) on 6ix